Physiologically based pharmacokinetic modeling of the drug drug interaction between rifampin and SGLT2 inhibitors: The contribution of CYP induction to the observed interaction
Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data
Tags: ansamycin, antibiotic, Legionnaire's disease, leprosy, polyketide, Rifadin®, rifampicin, tuberculosis
BASi Method Number SAP.1057
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
